People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kythera Biopharmaceuticals Inc | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2011 |
John Smither at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Smither on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| David Schnell | 1 | 7 |
| Camille Samuels | 1 | 6 |
| Dennis Fenton | 1 | 4 |
| Hironori Hozoji | 1 | 4 |
| Joseph Turner | 1 | 4 |
| Nathaniel David | 1 | 3 |
| Keith Leonard | 1 | 3 |
| Francois Kress | 1 | 3 |
| Keith Klein | 1 | 2 |
| Patricia Walker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.